AURA BIOSCIENCES INC's ticker is and the CUSIP is 05153U107. A total of 50 filers reported holding AURA BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,081,284 | +45.8% | 143,027 | +51.4% | 0.00% | – |
| Q1 2024 | $741,651 | -7.3% | 94,478 | +4.6% | 0.00% | – |
| Q4 2023 | $799,926 | +6.4% | 90,285 | +7.7% | 0.00% | – |
| Q3 2023 | $752,072 | -26.4% | 83,843 | +1.4% | 0.00% | – |
| Q2 2023 | $1,021,629 | +70.3% | 82,723 | +27.9% | 0.00% | – |
| Q1 2023 | $600,035 | +14.1% | 64,659 | +29.1% | 0.00% | – |
| Q4 2022 | $526,009 | -42.3% | 50,096 | -0.5% | 0.00% | – |
| Q3 2022 | $912,000 | +60.3% | 50,336 | +25.5% | 0.00% | – |
| Q2 2022 | $569,000 | +78.4% | 40,096 | +176.6% | 0.00% | – |
| Q1 2022 | $319,000 | – | 14,496 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $31,918,866 | 13.40% |
| Regency Capital Management Inc.\DE | 554,286 | $5,820,003 | 6.69% |
| Decheng Capital Management III (Cayman), LLC | 293,333 | $3,079,997 | 1.15% |
| Matrix Capital Management Company, LP | 5,362,870 | $56,310,135 | 1.08% |
| Monashee Investment Management LLC | 131,640 | $1,382,220 | 0.60% |
| Nantahala Capital Management | 798,751 | $8,386,886 | 0.54% |
| Eventide Asset Management | 2,251,368 | $23,639,364 | 0.47% |
| Rock Springs Capital Management LP | 1,019,757 | $10,707,449 | 0.26% |
| Artal Group S.A. | 410,000 | $4,305 | 0.24% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,132,739 | $22,393,760 | 0.05% |